Nascent Begins Enrollment of Final Patient Cohort to Complete Phase One Clinical Research

Retrieved on: 2022-10-05 00:06:31

Tags for this article:

Click the tags to see associated articles and topics

Nascent Begins Enrollment of Final Patient Cohort to Complete Phase One Clinical Research. View article details on hiswai:

Excerpt

... development of monoclonal antibodies targeting various cancer types, ... PTB is a natural human antibody that binds to Cell surface Vimentin ...

Article found on: www.digitaljournal.com